BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38025188)

  • 1. Immunohistochemical Evaluation of p16 and p53 in Oral and Oropharyngeal Squamous Cell Carcinoma with Special Regard to Human Papillomavirus Status.
    Ghosh U; Tripathy R; Lenka A; Turuk J; Mohapatra D
    J Microsc Ultrastruct; 2023; 11(3):172-178. PubMed ID: 38025188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status.
    Benzerdjeb N; Tantot J; Blanchet C; Philouze P; Mekki Y; Lopez J; Devouassoux-Shisheboran M
    Histopathology; 2021 Sep; 79(3):381-390. PubMed ID: 33560536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16 overexpression identifies oncogenic high-risk HPV infection in non-oropharyngeal squamous cell carcinoma of the head and neck.
    Becker AS; Merkel J; Bozkurt I; Strüder DF; Maletzki C; Hühns M; Zimpfer AH
    Head Neck; 2024 Apr; ():. PubMed ID: 38594829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
    Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
    BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization.
    Pannone G; Rodolico V; Santoro A; Lo Muzio L; Franco R; Botti G; Aquino G; Pedicillo MC; Cagiano S; Campisi G; Rubini C; Papagerakis S; De Rosa G; Tornesello ML; Buonaguro FM; Staibano S; Bufo P
    Infect Agent Cancer; 2012 Feb; 7():4. PubMed ID: 22376902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus co-infection and survival in oral and oropharyngeal squamous cell carcinoma: A study in 235 Brazilian patients.
    Silveira HA; Almeida LY; Carlos R; Silva EV; Ferrisse TM; Duarte A; Cardoso SCS; Polanco XBJ; Bufalino A; Ribeiro-Silva A; León JE
    Auris Nasus Larynx; 2022 Apr; 49(2):258-270. PubMed ID: 34274177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.
    Kawakami H; Okamoto I; Terao K; Sakai K; Suzuki M; Ueda S; Tanaka K; Kuwata K; Morita Y; Ono K; Nishio K; Nishimura Y; Doi K; Nakagawa K
    Cancer Med; 2013 Dec; 2(6):933-41. PubMed ID: 24403267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16 - a Possible Surrogate Marker for High-Risk Human Papillomaviruses in Oral Cancer?
    Sritippho T; Pongsiriwet S; Lertprasertsuke N; Buddhachat K; Sastraruji T; Iamaroon A
    Asian Pac J Cancer Prev; 2016; 17(8):4049-57. PubMed ID: 27644660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Kwon S; Ahn SH; Jeong WJ; Jung YH; Bae YJ; Paik JH; Chung JH; Kim H
    J Transl Med; 2020 Jun; 18(1):240. PubMed ID: 32546279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.
    Hauck F; Oliveira-Silva M; Dreyer JH; Perrusi VJ; Arcuri RA; Hassan R; Bonvicino CR; Barros MH; Niedobitek G
    Virchows Arch; 2015 Jun; 466(6):685-93. PubMed ID: 25820374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of p16 as a surrogate marker for transcriptionally active human papillomavirus status of oropharyngeal squamous cell carcinoma in an eastern Chinese population.
    Xu S; Sun B; Zhou R; Shi C; Han Y; Li J; Sun J; Tian Z; Zhang Z; Li J
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):236-245.e2. PubMed ID: 31987673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of p16
    Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
    Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion of an E7 DNA Amplification Test Improves the Robustness of Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma Diagnosis.
    Perera PY; Perera LP; Filkoski L; Chen W; Lichy JH; Paal E; Maxwell JH
    World J Oncol; 2020 Feb; 11(1):1-8. PubMed ID: 32095184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16 and p53 in HPV-positive versus HPV-negative oral squamous cell carcinoma: do pathways differ?
    Singh V; Husain N; Akhtar N; Khan MY; Sonkar AA; Kumar V
    J Oral Pathol Med; 2017 Oct; 46(9):744-751. PubMed ID: 28186650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
    Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
    Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of evidence of human papillomavirus-induced squamous cell carcinomas of the oral cavity in southern Germany.
    Reuschenbach M; Kansy K; Garbe K; Vinokurova S; Flechtenmacher C; Toth C; Prigge ES; Thiele OC; Reinert S; Hoffmann J; von Knebel Doeberitz M; Freier K
    Oral Oncol; 2013 Sep; 49(9):937-942. PubMed ID: 23608471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.